RayzeBio, Inc.
RYZBDelisted Feb 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001825367
RayzeBio, Inc. was delisted on Feb 26, 2024; its insiders filed their last Form 4 on Feb 28, 2024; 107 institutions reported holding it in 13F filings for Q4 2023, worth $3.40B in total; superinvestors Viking Global Investors and HHLR Advisors (Hillhouse) held it.
Q3 2023 vs. Q2 2023
How the institutions holding RayzeBio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 68 | +68 |
| Shares | 0 | 54.2M | +54.2M |
| Value | $0 | $1.20B | +$1.20B |
New holders (68)
Institutions that held RayzeBio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (0)
Institutions that held RayzeBio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.